For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of VILIN BIO MED. For more details, see the VILIN BIO MED quarterly results and VILIN BIO MED share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -4.0 |
No. of shares | m | 13.95 |
1 Week | % | -16.3 |
1 Month | % | -8.5 |
1 Year | % | - |
52 week H/L | Rs | 30.5/18.1 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VILIN BIO MED EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | ||
Low | Rs | NA | NA | NA | NA | ||
Sales per share (Unadj.) | Rs | 50.9 | 35.5 | 34.0 | 12.4 | ||
Earnings per share (Unadj.) | Rs | 0.5 | 0.4 | 0.1 | 1.3 | ||
Diluted earnings per share | Rs | 0.1 | 0.1 | 0.0 | 0.9 | ||
Cash flow per share (Unadj.) | Rs | 1.4 | 1.1 | 0.8 | 1.4 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 21.9 | 22.3 | 22.4 | 10.7 | ||
Adj. book value per share | Rs | 5.2 | 5.3 | 5.3 | 7.7 | ||
Shares outstanding (eoy) | m | 3.30 | 3.30 | 3.30 | 9.95 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 0 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 0 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | ||
Dividend payout | % | 0 | 0 | 0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | ||
Total wages/salary | Rs m | 12 | 9 | 8 | 8 |
VILIN BIO MED INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 168 | 117 | 112 | 123 | ||
Other income | Rs m | 0 | 0 | 0 | 0 | ||
Total revenues | Rs m | 168 | 117 | 112 | 123 | ||
Gross profit | Rs m | 9 | 8 | 8 | 26 | ||
Depreciation | Rs m | 3 | 3 | 2 | 2 | ||
Interest | Rs m | 4 | 4 | 5 | 6 | ||
Profit before tax | Rs m | 2 | 2 | 0 | 18 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 0 | 0 | 0 | 5 | ||
Profit after tax | Rs m | 2 | 1 | 0 | 12 | ||
Gross profit margin | % | 5.3 | 7.1 | 6.8 | 20.9 | ||
Effective tax rate | % | 16.3 | 24.7 | 24.7 | 30.1 | ||
Net profit margin | % | 1.0 | 1.0 | 0.3 | 10.1 |
VILIN BIO MED BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 118 | 120 | 119 | 133 | ||
Current liabilities | Rs m | 67 | 55 | 54 | 65 | ||
Net working cap to sales | % | 30.5 | 55.6 | 58.3 | 55.1 | ||
Current ratio | x | 1.8 | 2.2 | 2.2 | 2.0 | ||
Inventory Days | Days | 1 | 2 | 0 | 86 | ||
Debtors Days | Days | 1,578 | 2,382 | 2,534 | 2,927 | ||
Net fixed assets | Rs m | 22 | 19 | 17 | 44 | ||
Share capital | Rs m | 33 | 33 | 33 | 100 | ||
"Free" reserves | Rs m | 39 | 41 | 41 | 7 | ||
Net worth | Rs m | 72 | 74 | 74 | 107 | ||
Long term debt | Rs m | 0 | 10 | 7 | 4 | ||
Total assets | Rs m | 140 | 139 | 136 | 177 | ||
Interest coverage | x | 1.5 | 1.4 | 1.1 | 3.8 | ||
Debt to equity ratio | x | 0 | 0.1 | 0.1 | 0 | ||
Sales to assets ratio | x | 1.2 | 0.8 | 0.8 | 0.7 | ||
Return on assets | % | 4.0 | 4.1 | 4.0 | 10.7 | ||
Return on equity | % | 2.2 | 1.6 | 0.5 | 11.7 | ||
Return on capital | % | 8.3 | 7.2 | 6.8 | 21.9 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 0 | 0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | ||
Fx inflow | Rs m | 0 | 0 | 0 | 0 | ||
Fx outflow | Rs m | 0 | 0 | 0 | 0 | ||
Net fx | Rs m | 0 | 0 | 0 | 0 |
VILIN BIO MED CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -15 | -10 | 2 | -17 | ||
From Investments | Rs m | -0 | 0 | 0 | -0 | ||
From Financial Activity | Rs m | 15 | 10 | -2 | 17 | ||
Net Cashflow | Rs m | 0 | -0 | -0 | -0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Veerareddy Vallapureddy | COMP SEC: Ashdeep Kaur | YEAR OF INC: 2005 | NSE CODE: 677730 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VILIN BIO MED With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.